Main content
'Not too late to review cost' of breast cancer drug Kadcyla
The NHS has rejected a drug that can extend lives of women with breast cancer because it is 鈥榯oo expensive鈥�. Jennifer Cozzone head of Health Economics and Pricing at Roche and Mia Rosenblatt from Breast Cancer Campaign discuss.
Duration:
This clip is from
Featured in...
![]()
Health clips
Listen to a selection of clips from recent and upcoming programmes.
More clips from Today
-
![]()
Chimamanda Ngozi Adichie: AI will make us 'increasingly stupid'
Duration: 07:52
-
![]()
Crumbling Germany - why 'it's a bit broken'
Duration: 08:50
-
![]()
Met chief: New rules needed 'in weeks' to sack rogue officers
Duration: 12:16
-
![]()
Tom Kingston's family call for antidepressant change
Duration: 15:48
